Bristol-Myers (BMY) stock Forecast for 2022 – 2026
Last update: 05-24-2022, 5:52
Sector: HealthcareThe share price of Bristol-Myers Squibb Company (BMY) now
What analysts predict:: $79.16
52-week high/low: $78.43 / $52.37
50/200 Day Moving Average: $74.09 / $65.39
This figure corresponds to the average price over the previous 50/200 days. For Bristol-Myers stocks, the 50-day moving average is the support level today.
For Bristol-Myers stocks, the 200-day moving average is the support level today.
Are you interested in Bristol-Myers Squibb Company stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Bristol-Myers stock price in 2022, 2023, 2024, 2025, 2026. How much will one Bristol-Myers share be worth in 2022 - 2026?
When should I take profit in Bristol-Myers stock? When should I record a loss on Bristol-Myers stock? What are analysts' forecasts for Bristol-Myers stock? What is the future of Bristol-Myers stock?
We forecast Bristol-Myers stock performance using neural networks based on historical data on Bristol-Myers stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Bristol-Myers stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026)
The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Bristol-Myers shares. This happens once a day.
Historical and forecast chart of Bristol-Myers stock
The chart below shows the historical price of Bristol-Myers stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Bristol-Myers stock price can be found in the table below.
Long-term forecasts by years.
Bristol-Myers daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| May 26 | 77.77 | 77.35 | 78.03 | 0.87 |
| May 27 | 77.41 | 77.15 | 78.13 | 1.28 |
| May 28 | 76.41 | 76.19 | 77.04 | 1.12 |
| May 29 | 76.09 | 75.46 | 76.72 | 1.67 |
| May 30 | 77.06 | 76.74 | 77.51 | 1.01 |
| May 31 | 76.61 | 76.05 | 77.16 | 1.47 |
| Jun 01 | 76.66 | 76.21 | 77.15 | 1.24 |
| Jun 02 | 76.14 | 75.38 | 76.99 | 2.14 |
| Jun 03 | 75.45 | 75.10 | 76.17 | 1.42 |
| Jun 04 | 75.35 | 75.12 | 75.63 | 0.67 |
| Jun 05 | 74.72 | 73.89 | 75.40 | 2.05 |
| Jun 06 | 74.40 | 73.80 | 74.63 | 1.13 |
| Jun 07 | 75.35 | 74.58 | 76.10 | 2.04 |
| Jun 08 | 76.18 | 75.75 | 76.98 | 1.62 |
| Jun 09 | 77.04 | 76.70 | 77.27 | 0.75 |
| Jun 10 | 77.21 | 76.85 | 77.57 | 0.94 |
| Jun 11 | 76.92 | 76.46 | 77.41 | 1.24 |
| Jun 12 | 76.74 | 76.11 | 77.20 | 1.44 |
| Jun 13 | 76.66 | 75.87 | 77.21 | 1.77 |
| Jun 14 | 75.66 | 75.16 | 76.18 | 1.35 |
| Jun 15 | 75.94 | 75.53 | 76.23 | 0.93 |
| Jun 16 | 75.19 | 74.59 | 75.53 | 1.26 |
| Jun 17 | 75.48 | 74.89 | 75.72 | 1.10 |
| Jun 18 | 76.39 | 75.64 | 77.08 | 1.89 |
| Jun 19 | 76.97 | 76.32 | 77.51 | 1.55 |
| Jun 20 | 76.77 | 76.42 | 77.15 | 0.96 |
| Jun 21 | 76.82 | 76.27 | 77.39 | 1.47 |
| Jun 22 | 77.28 | 76.47 | 78.02 | 2.02 |
| Jun 23 | 76.77 | 76.16 | 77.41 | 1.64 |
| Jun 24 | 77.18 | 76.65 | 77.99 | 1.75 |
Bristol-Myers Daily Price Targets
Bristol-Myers Stock Forecast 05-26-2022.
Pessimistic target level: 77.35
Optimistic target level: 78.03
Bristol-Myers Stock Forecast 05-27-2022.
Pessimistic target level: 77.15
Optimistic target level: 78.13
Bristol-Myers Stock Forecast 05-28-2022.
Pessimistic target level: 76.19
Optimistic target level: 77.04
Bristol-Myers Stock Forecast 05-29-2022.
Pessimistic target level: 75.46
Optimistic target level: 76.72
Bristol-Myers Stock Forecast 05-30-2022.
Pessimistic target level: 76.74
Optimistic target level: 77.51
Bristol-Myers Stock Forecast 05-31-2022.
Pessimistic target level: 76.05
Optimistic target level: 77.16
BMY (BMY) Monthly Stock Prediction for 2022
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jun. | 81.19 | 79.76 | 82.08 | 2.83 |
| Jul. | 84.36 | 80.97 | 85.75 | 5.57 |
| Aug. | 85.43 | 83.03 | 86.88 | 4.43 |
| Sep. | 82.00 | 78.66 | 85.47 | 7.97 |
| Oct. | 83.94 | 81.49 | 85.27 | 4.44 |
| Nov. | 86.20 | 84.73 | 88.00 | 3.72 |
| Dec. | 86.39 | 83.16 | 90.14 | 7.75 |
Bristol-Myers forecast for this year
Bristol-Myers Stock Prediction for Jun 2022
An uptrend is forecast for this month with an optimal target price of $81.1884. Pessimistic: $79.76. Optimistic: $82.08
Bristol-Myers Stock Prediction for Jul 2022
An uptrend is forecast for this month with an optimal target price of $84.3589. Pessimistic: $80.97. Optimistic: $85.75
Bristol-Myers Stock Prediction for Aug 2022
An uptrend is forecast for this month with an optimal target price of $85.426. Pessimistic: $83.03. Optimistic: $86.88
Bristol-Myers Stock Prediction for Sep 2022
An downtrend is forecast for this month with an optimal target price of $81.9961. Pessimistic: $78.66. Optimistic: $85.47
Bristol-Myers Stock Prediction for Oct 2022
An uptrend is forecast for this month with an optimal target price of $83.9354. Pessimistic: $81.49. Optimistic: $85.27
Bristol-Myers Stock Prediction for Nov 2022
An uptrend is forecast for this month with an optimal target price of $86.1974. Pessimistic: $84.73. Optimistic: $88.00
Bristol-Myers Stock Prediction for Dec 2022
An uptrend is forecast for this month with an optimal target price of $86.387. Pessimistic: $83.16. Optimistic: $90.14
Bristol-Myers (BMY) Monthly Stock Prediction for 2023
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 84.77 | 83.05 | 88.18 | 5.82 |
| Feb | 83.79 | 80.70 | 84.81 | 4.84 |
| Mar | 83.88 | 81.81 | 85.50 | 4.32 |
| Apr | 82.64 | 79.18 | 84.23 | 5.99 |
| May | 80.00 | 76.92 | 83.08 | 7.41 |
| Jun | 83.30 | 80.10 | 85.36 | 6.17 |
| Jul | 84.68 | 82.81 | 86.77 | 4.56 |
| Aug | 88.08 | 85.95 | 90.64 | 5.18 |
| Sep | 86.24 | 84.67 | 89.56 | 5.45 |
| Oct | 86.95 | 84.22 | 88.14 | 4.45 |
| Nov | 86.13 | 82.34 | 89.59 | 8.09 |
| Dec | 89.31 | 87.10 | 90.44 | 3.69 |
Bristol-Myers (BMY) Monthly Stock Prediction for 2024
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 85.13 | 82.84 | 88.18 | 6.05 |
| Feb | 82.51 | 80.02 | 84.51 | 5.32 |
| Mar | 82.38 | 80.43 | 85.77 | 6.23 |
| Apr | 79.84 | 76.81 | 82.39 | 6.77 |
| May | 81.20 | 77.72 | 82.23 | 5.49 |
| Jun | 85.44 | 84.08 | 88.07 | 4.54 |
| Jul | 83.14 | 80.03 | 86.80 | 7.80 |
| Aug | 86.25 | 85.30 | 87.81 | 2.86 |
| Sep | 84.07 | 81.80 | 87.40 | 6.40 |
| Oct | 83.56 | 80.57 | 84.52 | 4.68 |
| Nov | 84.89 | 81.25 | 87.18 | 6.80 |
| Dec | 84.14 | 80.63 | 87.34 | 7.68 |
Bristol-Myers (BMY) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 86.55 | 83.31 | 88.93 | 6.32 |
| Feb | 86.60 | 83.65 | 89.74 | 6.79 |
| Mar | 87.74 | 84.70 | 91.02 | 6.95 |
| Apr | 86.73 | 85.30 | 87.68 | 2.72 |
| May | 84.77 | 82.21 | 88.08 | 6.67 |
| Jun | 88.50 | 87.19 | 90.60 | 3.76 |
| Jul | 86.17 | 84.65 | 88.68 | 4.54 |
| Aug | 90.72 | 88.17 | 93.76 | 5.96 |
| Sep | 93.11 | 90.40 | 96.08 | 5.92 |
| Oct | 93.78 | 92.38 | 95.07 | 2.82 |
| Nov | 93.36 | 91.51 | 96.55 | 5.21 |
| Dec | 91.98 | 90.41 | 93.54 | 3.35 |
Bristol-Myers (BMY) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 91.93 | 90.81 | 94.25 | 3.65 |
| Feb | 94.86 | 91.52 | 96.37 | 5.03 |
| Mar | 98.25 | 96.74 | 100.36 | 3.61 |
| Apr | 102.95 | 100.52 | 105.61 | 4.83 |
| May | 108.39 | 104.15 | 112.08 | 7.07 |
| Jun | 107.97 | 106.37 | 109.93 | 3.24 |
| Jul | 105.30 | 103.21 | 107.15 | 3.68 |
| Aug | 102.58 | 100.77 | 106.64 | 5.50 |
| Sep | 98.01 | 94.99 | 101.35 | 6.28 |
| Oct | 98.01 | 96.55 | 100.05 | 3.50 |
| Nov | 100.00 | 97.42 | 103.91 | 6.25 |
| Dec | 96.32 | 94.30 | 98.17 | 3.94 |
Bristol-Myers information and performance
Bristol-Myers Squibb is an American pharmaceutical company. Develops drugs in various areas of medicine, including: oncology, HIV / acquired immunodeficiency syndrome, cardiovascular diseases, diabetes, hepatitis B and C, rheumatoid arthritis and mental disorders. The mission of the company is to discover, develop and supply innovative medicines to patients so that they can overcome serious illnesses. The mission also means that the company is working to ensure that patients have access to healthcare through public and private partners. The firm’s strategy combines the scale and resources of a large pharmaceutical corporation with the entrepreneurial spirit and agility of a successful biotech firm.
Bristol-Myers Squibb started out as two different companies – Bristol-Myers and Squibb. The Squibb Corporation was formed in 1858 in Brooklyn, New York. Founder Edward Robinson Squibb was a preeminent proponent of quality control and high purity standards within the emerging pharmaceutical industry of his day. After a failed attempt to convince the American Medical Association to accept higher frequency standards, he independently published an alternative to the US Pharmacopoeia (Squibb’s Ephemeris of Materia Medica). In 1887, Hamilton College alumni William McLaren Bristol and John Ripley Myers bought Clinton Pharmaceutical from Clinton, Oneida County, New York. After Myers’ death in 1899, Bristol changed its name to Bristol-Myers Corporation. The first nationally recognized product was Sal Hepatica, a laxative mineral salt in 1903. Its second national success was the Ipana toothpaste, from 1901 to 1960. The second national success was with Ipana toothpaste, from 1901 to 1960. Bristol-Myers and Squibb merged to form Bristol-Myers Squibb in 1989.
Bristol-Myers Address
430 E. 29TH STREET, 14 FLOOR, NEW YORK, NY, US
Market Capitalization: 166 535 070 000 $
Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.
EBITDA: 21 133 251 000 $
EBITDA is earnings before interest, income tax and depreciation of assets.
PE Ratio: 27.71
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
PEG Ratio: 2.437
Price/earnings to growth
DPS: 2.06
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
DY: 0.0281
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS: 2.823
EPS shows how much of the net profit is accounted for by the common share.
Quarterly Earnings Growth YOY: -0.337
Quarterly Revenue Growth YOY: 0.052
Trailing PE: 27.71
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward PE: 9.76
Forward P/E uses projections of future earnings instead of final numbers.
EV To Revenue: 4.093
Enterprise Value (EV) /Revenue
EV To EBITDA: 10.03
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Shares Outstanding: 2129060000
Number of issued ordinary shares
Shares Float: N/A
Number of freely tradable shares
Shares Short Prior Month: N/A
Shares Short Prior Month - the number of shares in short positions in the last month.
Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A
Bristol-Myers (BMY) stock dividend
Bristol-Myers last paid dividends on 03/31/2022. The next scheduled payment will be on 05/02/2022. The amount of dividends is $2.06 per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.
Last Split Factor:
Last Split Date: 01/01/1970
Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.
For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.